American Healthcare REIT, Inc. (AHR)
NYSE • Real Estate
Last close at October 8, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, American Healthcare REIT, Inc. keeps $5 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 27 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
American Healthcare REIT’s EPS of $0.16 topped the $0.14 estimate, about +17%, and rose from $0.06 a year ago in the second fiscal quarter of 2026, based on preliminary results reported on Aug. 6. The company repurchased about $9.8 million of stock and paid about $46.8 million in dividends.
Next report — what to expect
American Healthcare REIT, Inc. (AHR) is set to report earnings on November 5, 2026. Wall Street expects EPS of $0.154 on revenue of $698.4 million. For trailing context, revenue grew +24.3% year over year last quarter. AHR has beaten EPS in 1 of its 8 most recent quarters.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. (NYSE: AHR) is a real estate company focused on healthcare properties, owning and operating facilities such as medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. Across this healthcare real estate portfolio, the company generated $2.3 billion of revenue in FY2025.
Today's Snapshot
The day ended with AHR 2.2% higher at 50.44, in line with a firmer sector.
Trading Volume
Above 10d avg 3.1M
3.3M
vs S&P 500 Today
Outperforming Market
+2.71%
Updated: October 8, 2026 at 20:16 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$50.85 - $52.88Sell
- RSI (14)36.19Neutral
- Stochastic %K (14, 3, 3)14.88Buy
- MACD Level (12, 26)-1.11Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.